CVE-2026-21974 Information disclosure in Oracle Life Sciences Central Designer

Medium 5.3 Published 20 Jan 2026 Updated 21 Jan 2026

Unauthenticated attackers can read a subset of data in Oracle Life Sciences Central Designer via HTTP.

Exploited in the wild: Not known
Login needed: Not needed
Attackable: Over the internet
Victim action needed: Not needed
Fix: None listed

What is CVE-2026-21974?

CVE-2026-21974 is a medium-severity vulnerability in Oracle Life Sciences Central Designer, published on 20 Jan 2026. An attacker can exploit it over the internet without logging in, with no action from the victim.

Official description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

Weakness: CWE-200

Which versions are affected by CVE-2026-21974?

It affects 1 product.

Products include Oracle Life Sciences Central Designer.

How do I fix CVE-2026-21974?

No fix has been published for CVE-2026-21974 yet. Limit exposure of the affected software until one is available.

Is CVE-2026-21974 being exploited?

There is no known exploitation of CVE-2026-21974 in the wild and no public exploit code.

Sources

Also known as GHSA-vpg5-x373-3q2c.